ConductScience.org, home

Trial · NCT03340064

Results by group515

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percent Change in Partial Seizure Frequency Per Week From Baseline to Visit 6Levetiracetam: Adjunctive Therapy24.2495% Confidence Interval -25.48 to 51.85percent change
Percent Change in Partial Seizure Frequency Per Week From Baseline to Visit 4Levetiracetam: Adjunctive Therapy8.62Full Range -343.1 to 100.0percent change
Percent Change in Partial Seizure Frequency Per Week From Baseline to Visit 5Levetiracetam: Adjunctive Therapy16.79Full Range -414.3 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 835.53Full Range -137.9 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 1059.39Full Range -138.2 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 1250.90Full Range -167.8 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 1560.29Full Range -129.4 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 1882.74Full Range -22.3 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 2180.33Full Range -44.1 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 2488.44Full Range -97.8 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 2793.84Full Range -4.8 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 3098.05Full Range -4.8 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 36100.00Full Range -94.5 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 4898.70Full Range -28.4 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 60100.00Full Range 44.7 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 72100.00Full Range 32.0 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 84100.00Full Range 62.9 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 9699.57Full Range 78.2 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 108100.00Full Range -48.0 to 100.0percent change
Percent Change From Baseline for Each Analysis Visit in Partial Seizure Frequency Per Week on Adjunctive TherapyLevetiracetam: Adjunctive TherapyWeek 120100.00Full Range 80.4 to 100.0percent change

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03340064/results